Basic Prevention and Management of Common Musculoskeletal Disorders
While at increased risk for these injuries, dental hygienists can implement strategies for effective prevention and care to ensure the longevity of their careers.
New Expert on Fluoride to Answer Reader Questions
Dimensions of Dental Hygiene is excited to announce the addition of Denise Muesch Helm, RDH, EdD, as the new expert on fluoride in the online and in-print “As the Expert” forum.
Gut Bacteria Linked to Long COVID-19 Illness
A study found that those with long COVID-19 illness (symptoms lasting more than 30 days post-infection) had lower levels of immunity-enhancing gut bacteria, such as Bifidobacterium pseudocatenulatum, Faecalibacterium prausnitzii, Roseburia…
N95 Masks Can Be Reused, Length of Wear Determines Effectiveness
With the highly transmissible Omicron now the dominant variant of COVID-19 and data showing that cloth masks are not very effective, demand for high-quality N95 masks has grown. The United States Centers for Disease Control and Prevention…
Vaccine and Infection Provide Immunity Boost, Regardless of Which Comes First
A new study found that whether you are infected with COVID-19 first and then get vaccinated or you experience a breakthrough infection post-vaccination, the results are the same: a big boost of immunity. Published in Science Immunology, the…
CDA Advises Dental Practices on Notification Protocol for COVID-19 Exposure
The California Dental Association (CDA) released some simple tips for dental practices that are unsure of when to notify patients of a COVID-19 exposure in the office. The organization suggests a patient be notified if he or she was within…
Omicron Has More Staying Power Than Other Variants But Can’t Survive Hand Sanitizer
The bad news is that a Japanese study found the Omicron variant of SARS-CoV-2 remains viable longer on plastic and skin than other variants. The good news is that it cannot survive hand sanitizer. Omicron’s staying power may have…
Clinical Trial of an Omicron-Targeting Vaccine Is Ready to Begin
As Americans’ COVID-19 fatigue continues to grow, Pfizer announced it will begin a clinical trial on a COVID-19 vaccine designed to target the highly transmissible Omicron variant of SARS-CoV-2. Pfizer’s original two-dose COVID-19 vaccine…
While Private Insurers Must Cover Rapid COVID-19 Tests, Medicare Does Not
On January 15, the White House announced that private health insurance companies will be required to cover the cost of eight rapid at-home COVID-19 tests per month. However, Medicare, the insurance program that covers adults ages 65 and…
Omicron COVID-19 Surge Seems to Be Abating
A Reuters analysis of COVID-19 cases in the United States has found that cases are declining in regions that first experienced an Omicron-fueled spike. Nineteen states, Washington, DC, and Puerto Rico have all seen dips in new COVID-19…
- Advertisement -
